ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P11474


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name ERR1_HUMAN
Primary accession number P11474
Secondary accession number Q14514
Integrated into Swiss-Prot on October 1, 1989
Sequence was last modified on November 25, 2008 (Sequence version 3)
Annotations were last modified on    June 16, 2009 (Entry version 110)
Name and origin of the protein
Protein name Steroid hormone receptor ERR1
Synonyms Estrogen-related receptor, alpha
ERR-alpha
Estrogen receptor-like 1
Nuclear receptor subfamily 3 group B member 1
Gene name
Name: ESRRA
Synonyms: ERR1, ESRL1, NR3B1
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
TISSUE=Kidney;
DOI=10.1038/331091a0; PubMed=3267207 [NCBI, ExPASy, EBI, Israel, Japan]
Giguere V., Yang N., Segui P., Evans R.M.;
"Identification of a new class of steroid hormone receptors.";
Nature 331:91-94(1988).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
TISSUE=Uterus;
DOI=10.1074/jbc.271.10.5795; PubMed=8621448 [NCBI, ExPASy, EBI, Israel, Japan]
Yang N., Shigeta H., Shi H., Teng C.T.;
"Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter.";
J. Biol. Chem. 271:5795-5804(1996).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04632; PubMed=16554811 [NCBI, ExPASy, EBI, Israel, Japan]
Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S., Sakaki Y.;
"Human chromosome 11 DNA sequence and analysis including novel gene identification.";
Nature 440:497-500(2006).
[4]
PROTEIN SEQUENCE OF 69-76.
PubMed=8224847 [NCBI, ExPASy, EBI, Israel, Japan]
Wiley S.R., Kraus R.J., Zuo F., Murray E.E., Loritz K., Mertz J.E.;
"SV40 early-to-late switch involves titration of cellular transcriptional repressors.";
Genes Dev. 7:2206-2219(1993).
[5]
FUNCTION.
PubMed=9271417 [NCBI, ExPASy, EBI, Israel, Japan]
Sladek R., Bader J.-A., Giguere V.;
"The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene.";
Mol. Cell. Biol. 17:5400-5409(1997).
[6]
INTERACTION WITH PPARGC1A, INDUCTION, AND FUNCTION.
DOI=10.1074/jbc.M212923200; PubMed=12522104 [NCBI, ExPASy, EBI, Israel, Japan]
Schreiber S.N., Knutti D., Brogli K., Uhlmann T., Kralli A.;
"The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).";
J. Biol. Chem. 278:9013-9018(2003).
[7]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-27, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0404720101; PubMed=15302935 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
[8]
DNA-BINDING SPECIFICITY, INTERACTION WITH PPARGC1A, HOMODIMERIZATION, FUNCTION, AND MUTAGENESIS OF SER-118 AND THR-124.
DOI=10.1210/me.2005-0313; PubMed=16150865 [NCBI, ExPASy, EBI, Israel, Japan]
Barry J.B., Laganiere J., Giguere V.;
"A single nucleotide in an estrogen-related receptor alpha site can dictate mode of binding and peroxisome proliferator-activated receptor gamma coactivator 1alpha activation of target promoters.";
Mol. Endocrinol. 20:302-310(2006).
[9]
SUMOYLATION AT LYS-14 AND LYS-403, PHOSPHORYLATION AT SER-19 AND SER-22, FUNCTION, AND MUTAGENESIS OF LYS-14; SER-19; SER-22; LYS-403; LEU-413 AND LEU-418.
DOI=10.1021/bi700316g; PubMed=17676930 [NCBI, ExPASy, EBI, Israel, Japan]
Vu E.H., Kraus R.J., Mertz J.E.;
"Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1.";
Biochemistry 46:9795-9804(2007).
[10]
SUMOYLATION AT LYS-14 AND LYS-403, PHOSPHORYLATION AT SER-19 AND SER-22, INTERACTION WITH PIAS4, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-14; SER-19; SER-22 AND LYS-403.
DOI=10.1210/me.2007-0357; PubMed=18063693 [NCBI, ExPASy, EBI, Israel, Japan]
Tremblay A.M., Wilson B.J., Yang X.-J., Giguere V.;
"Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif.";
Mol. Endocrinol. 22:570-584(2008).
[11]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-22, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[12]
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 193-423 IN COMPLEX WITH THE L3 SITE-CONTAINING PEPTIDE OF COACTIVATOR PPARGC1A, HOMODIMERIZATION, AND MASS SPECTROMETRY.
DOI=10.1074/jbc.M407999200; PubMed=15337744 [NCBI, ExPASy, EBI, Israel, Japan]
Kallen J., Schlaeppi J.-M., Bitsch F., Filipuzzi I., Schilb A., Riou V., Graham A., Strauss A., Geiser M., Fournier B.;
"Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.";
J. Biol. Chem. 279:49330-49337(2004).
[13]
X-RAY CRYSTALLOGRAPHY (2.11 ANGSTROMS) OF 180-423 IN COMPLEX WITH THE L3 SITE-CONTAINING PEPTIDE OF COACTIVATOR PPARGC1A, INTERACTION WITH PPARGC1A, AND MUTAGENESIS OF 258-MET--GLN-262; SER-259; ARG-315; ASP-338; HIS-341; GLU-343 AND 421-MET--ASP-423.
DOI=10.1074/jbc.M801920200; PubMed=18441008 [NCBI, ExPASy, EBI, Israel, Japan]
Greschik H., Althage M., Flaig R., Sato Y., Chavant V., Peluso-Iltis C., Choulier L., Cronet P., Rochel N., Schuele R., Stroemstedt P.E., Moras D.;
"Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.";
J. Biol. Chem. 283:20220-20230(2008).
Comments
  • FUNCTION: Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism.
  • SUBUNIT: Binds DNA as a monomer or a homodimer. Interacts (via the AF2 domain) with coactivator PPARGC1A (via the L3 motif); the interaction greatly enhances transriptional activity of genes involved in energy metabolism. Interacts with PIAS4; the interaction enhances sumoylation.
  • INTERACTION:
    Q9Y4A5:TRRAP; NbExp=1; IntAct=EBI-372412, EBI-399128;
  • SUBCELLULAR LOCATION: Nucleus.
  • ALTERNATIVE PRODUCTS: 2 named isoforms [FASTA] produced by alternative splicing.
    Name1
    Isoform IDP11474-1
    This is the isoform sequence displayed in this entry.
    Name2
    Isoform IDP11474-2
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_035756.
  • INDUCTION: Induced by PGC1alpha in a number of specific cell types including heart, kidney and muscle.
  • PTM: Phosphorylation on Ser-19 enhances sumoylation on Lys-14 increasing repression of transcriptional activity.
  • PTM: Sumoylated by SUMO2. Main site is Lys-14 which is enhanced by phosphorylation on Ser-19, cofactor activation, and by interaction with PIAS4. Sumoylation enhances repression of transcriptional activiy, but has no effect on subcellular location nor on DNA binding.
  • SIMILARITY: Belongs to the nuclear hormone receptor family. NR3 subfamily.
  • SIMILARITY: Contains 1 nuclear receptor DNA-binding domain.
  • SEQUENCE CAUTION:
    • Sequence=CAA35778.1; Type=Frameshift; Positions=345, 354;
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
X51416; CAA35778.1; ALT_FRAME; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L38487; AAB17015.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AP001453; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
IPI IPI00005717; -.
IPI00792208; -.
PIR A29345; A29345.
RefSeq NP_004442.3; -.
UniGene Hs.110849
3D structure databases
PDB
1XB7; X-ray; 2.50 A; A=193-423.[ExPASy / RCSB / EBI]
2PJL; X-ray; 2.30 A; A/B=193-423.[ExPASy / RCSB / EBI]
3D24; X-ray; 2.11 A; A/C=189-423.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1XB7; -.
2PJL; -.
3D24; -.
SMR P11474; 170-259.
ModBase P11474.
Protein-protein interaction databases
IntAct P11474; 3.
PTM databases
PhosphoSite P11474; -.
Organism-specific databases
GeneCards GC11P063829; -.
HGNC HGNC:3471; ESRRA.
GenAtlas ESRRA.
MIM 601998; gene. [NCBI / EBI]
PharmGKB PA27887; -.
Gene expression databases
Bgee P11474; -.
CleanEx HS_ESRRA; -.
GermOnline ENSG00000173153; Homo sapiens.
Ontologies
GO
GO:0005634; Cellular component: nucleus (traceable author statement from ProtInc).
GO:0019904; Molecular function: protein domain specific binding (inferred from physical interaction from UniProtKB).
GO:0043565; Molecular function: sequence-specific DNA binding (inferred from electronic annotation from InterPro).
GO:0005496; Molecular function: steroid binding (inferred from electronic annotation from InterPro).
GO:0003707; Molecular function: steroid hormone receptor activity (inferred from electronic annotation from InterPro).
GO:0008270; Molecular function: zinc ion binding (inferred from electronic annotation from UniProtKB-KW).
GO:0006350; Biological process: transcription (inferred from electronic annotation from UniProtKB-KW).
QuickGo view.
Family and domain databases
InterPro IPR008946; Nucl_hormone_rcpt_ligand-bd.
IPR000536; Nucl_hrmn_rcpt_lig-bd_core.
IPR000003; RtnoidX_rcpt.
IPR001723; Str_hrmn_rcpt.
IPR001628; Znf_hrmn_rcpt.
IPR013088; Znf_NHR/GATA.
Graphical view of domain structure.
Gene3D G3DSA:1.10.565.10; Nucl_hrmn_rcpt_lig_bd; 1.
G3DSA:3.30.50.10; Znf_NHR/GATA; 1.
Pfam PF00104; Hormone_recep; 1.
PF00105; zf-C4; 1.
Pfam graphical view of domain structure.
PRINTS PR00545; RETINOIDXR.
PR00398; STRDHORMONER.
PR00047; STROIDFINGER.
ProDom PD000035; Znf_C4steroid; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00430; HOLI; 1.
SM00399; ZnF_C4; 1.
SMART graphical view of domain structure.
PROSITE PS00031; NUCLEAR_REC_DBD_1; 1.
PS51030; NUCLEAR_REC_DBD_2; 1.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PRIDE P11474; -.
Genome annotation databases
Ensembl ENSG00000173153; Homo sapiens. [Contig view]
GeneID 2101; -.
KEGG hsa:2101; -.
Phylogenomic databases
HOGENOM P11474; -.
HOVERGEN P11474; -.
OMA P11474; VYIEDME.
Other
NextBio 8503; -.
SOURCE ESRRA; Homo sapiens.
ProtoNet P11474.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Direct protein sequencing; DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Receptor; Transcription; Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
CHAIN   1   423  423     Steroid hormone receptor ERR1. PRO_0000053660
DNA_BIND   76   151  76     Nuclear receptor. 
ZN_FING   79    99  21     NR C4-type. 
ZN_FING   115   134  20     NR C4-type. 
REGION   1    76  76     Repressor domain. 
REGION   206   402  197     Ligand binding domain. 
REGION   403   423  21     AF-2 domain. 
SITE   124   124  1     Required for DNA-dependent dimerization. 
MOD_RES   19    19        Phosphoserine. 
MOD_RES   22    22        Phosphoserine. 
MOD_RES   27    27        Phosphoserine. 
CROSSLNK   14    14        Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO). 
CROSSLNK   403   403        Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); partial. 
VAR_SEQ   191   191        Missing (in isoform 2). VSP_035756
MUTAGEN   14    14        K->R: Some loss of sumoylation. Complete loss of sumoylation; when associated with R-403. 
MUTAGEN   19    19        S->A: 50% loss of phosphorylation but represses transactivation activity in the absence of coactivator. Almost complete loss of phosphorylation and 2-fold loss of repression of transactivation activity in response to coactivator; when associated with A-22. 
MUTAGEN   19    19        S->D: Represses transactivation activity in response to coactivator as for wild type; when associated with D-22. 
MUTAGEN   22    22        S->A: 15% loss of phosphorylation but little transactivating activity. Almost complete loss of phosphorylation and 2-fold loss of repression of transactivation activity in the presence of coactivator; when associated with A-19. 
MUTAGEN   22    22        S->D: Represses transactivation activity in response to coactivator as for wild type; when associated with D-19. 
MUTAGEN   118   118        S->A: Binds DNA as a monomer or as a dimer as for wild type. No effect on interaction with PPARGC1A. 
MUTAGEN   124   124        T->A: Binds DNA predominantly as a monomer. Loss of interaction with PPARGC1A. 
MUTAGEN   258   262        MSVLQ->VSVLE: Almost complete loss of interaction to L2 or to L3 of PPARGC1A. 
MUTAGEN   259   259        S->H: Little effect on binding L2 of PPARGC1A. Greatly reduced binding to L3 of PPARGC1A. 
MUTAGEN   315   315        R->A: Almost complete loss of interaction to L2 or to L3 of PPARGC1A. 
MUTAGEN   338   338        D->A: Almost complete loss of interaction to L2 or to L3 of PPARGC1A. 
MUTAGEN   341   341        H->A: Little effect on binding L3 of PPARGC1A. 
MUTAGEN   343   343        E->A: No effect on binding L3 of PPARGC1A. 
MUTAGEN   403   403        K->R: Decrease in sumoylation. No effect on transcriptional activity. Complete loss of sumoylation; when associated with R-14. 
MUTAGEN   413   413        L->A: Loss of coactivation activity; when associated with A-418. Loss of increased response to coactivator; when associated with A-19 and A-418. 
MUTAGEN   418   418        L->A: Loss of coactivation activity; when associated with A-413. Loss of increased response to coactivator activity; when associated with A-19 and A-413. 
MUTAGEN   421   423        Missing: Greatly reduced interaction with L3 motif of PPARGC1A. Less effect on binding to L2 motif of PPARGC1A. 
MUTAGEN   423   423        D->A: Little effect on binding L3 of PPARGC1A. 
HELIX   194   203  10      
HELIX   225   243  19      
HELIX   249   251  3      
HELIX   254   275  22      
TURN   276   279  4      
STRAND   280   287  8      
STRAND   290   293  4      
HELIX   294   299  6      
HELIX   305   317  13      
TURN   318   320  3      
HELIX   323   335  13      
HELIX   345   364  20      
HELIX   376   382  7      
HELIX   385   402  18      
HELIX   404   406  3      
HELIX   409   419  11      
Sequence information
Length: 423 AA [This is the length of the unprocessed precursor] Molecular weight: 45510 Da [This is the MW of the unprocessed precursor] CRC64: BAE62DAF0BE6BA96 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MSSQVVGIEP LYIKAEPASP DSPKGSSETE TEPPVALAPG PAPTRCLPGH KEEEDGEGAG 

        70         80         90        100        110        120 
PGEQGGGKLV LSSLPKRLCL VCGDVASGYH YGVASCEACK AFFKRTIQGS IEYSCPASNE 

       130        140        150        160        170        180 
CEITKRRRKA CQACRFTKCL RVGMLKEGVR LDRVRGGRQK YKRRPEVDPL PFPGPFPAGP 

       190        200        210        220        230        240 
LAVAGGPRKT AAPVNALVSH LLVVEPEKLY AMPDPAGPDG HLPAVATLCD LFDREIVVTI 

       250        260        270        280        290        300 
SWAKSIPGFS SLSLSDQMSV LQSVWMEVLV LGVAQRSLPL QDELAFAEDL VLDEEGARAA 

       310        320        330        340        350        360 
GLGELGAALL QLVRRLQALR LEREEYVLLK ALALANSDSV HIEDAEAVEQ LREALHEALL 

       370        380        390        400        410        420 
EYEAGRAGPG GGAERRRAGR LLLTLPLLRQ TAGKVLAHFY GVKLEGKVPM HKLFLEMLEA 


MMD 

P11474 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!